Jazz Pharmaceuticals prices upsized $1.1B notes offer
Jazz Pharmaceuticals priced an upsized $1.1 billion private offering of 1.875% exchangeable senior notes due 2032. It will repurchase ordinary shares concurrently.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Jazz Pharmaceuticals announces private offering of 2032 exchangeable notes
Jazz Pharmaceuticals said it is offering $1.0 billion of exchangeable senior notes due 2032 via a private offering and will repurchase ordinary shares concurrently.